Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial
Options
BORIS DOI
Date of Publication
2012
Publication Type
Article
Division/Institute
Contributor
Behringer, K | |
Thielen, I | |
Mueller, H | |
Goergen, H | |
Eibl, A D | |
Rosenbrock, J | |
Halbsguth, T | |
Eichenauer, D A | |
Fuchs, M | |
Reiners, K S | |
Renno, J H | |
van der Ven, K | |
Kuehr, M | |
Diehl, V | |
Engert, A | |
Borchmann, P |
Series
Annals of oncology
ISSN or ISBN (if monograph)
0923-7534
Publisher
Oxford University Press
Language
English
Publisher DOI
PubMed ID
22228451
Description
In the HD14 trial, 2×BEACOPPescalated+2×ABVD (2+2) has improved the primary outcome. Compared with 4×ABVD, this benefit might be compromised by more infertility in women. Therefore, we analyzed gonadal function and fertility.
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| mdr575.pdf | text | Adobe PDF | 255.13 KB | publisher | published |